Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 10/20 | 0.44 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 7/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21747501 | 0.83 | NPSR1 (0.48) | CES1CTNNB1LMNASRCGAA | |
| SCHEMBL8459655 | 0.78 | CTNNB1 (0.61) | CES1CTNNB1CES2LMNASRC | |
| SCHEMBL30877132 | 0.78 | CES1 (0.51) | CES1CTNNB1CES2LMNAGAA | |
| SCHEMBL27447166 | 0.77 | CES1 (0.47) | CES1CES2LMNASRCGAA | |
| SCHEMBL10458191 | 0.77 | GAA (0.53) | CES1CES2LMNASRCGAA | |
| SCHEMBL10471882 | 0.77 | SRC (0.47) | CES1CES2LMNASRCGAA | |
| SCHEMBL28442493 | 0.77 | CES1 (0.47) | CES1CES2LMNASRCGAA | |
| SCHEMBL9617688 | 0.76 | SRC (0.46) | CES1CES2LMNASRCGAA | |
| SCHEMBL9630992 | 0.76 | CES1 (0.45) | CES1CTNNB1CES2LMNASRC | |
| SCHEMBL7088571 | 0.75 | CTNNB1 (0.54) | CES1CTNNB1CES2LMNASRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8796339-B2 | Compositions comprising benzyl alcohol derivatives and further antimicrobial active compounds | SYMRISE AG (DE) | 2014-08-05 | — | — | US | disclosed |
| US-20110152383-A1 | COMPOSITIONS COMPRISING BENZYL ALCOHOL DERIVATIVES AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS | SYMRISE AG (DE) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152383-A1 | COMPOSITIONS COMPRISING BENZYL ALCOHOL DERIVATIVES AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS | UNC93B1, ECI1, IL4I1 | CES1 216/4885CTNNB1 2989/4885CES2 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.